MeSH term
Frequency | Condition_Probility | Research Support, Non-U.S. Gov't | 55 | 0.0 |
Transfection | 4 | 0.0 |
Water/metabolism | 9 | 13.0 |
Animals | 49 | 0.0 |
Aquaporins/*genetics/*metabolism | 2 | 28.0 |
Kidney/*physiology | 3 | 7.0 |
Mice | 12 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Amino Acid Sequence | 18 | 0.0 |
Base Sequence | 9 | 0.0 |
Cloning, Molecular | 8 | 0.0 |
Humans | 62 | 0.0 |
Molecular Sequence Data | 19 | 0.0 |
Oocytes/physiology | 3 | 2.0 |
Sequence Alignment | 4 | 0.0 |
Tissue Distribution | 7 | 0.0 |
Xenopus | 6 | 1.0 |
Aquaporins/*biosynthesis | 2 | 66.0 |
Immunohistochemistry | 11 | 0.0 |
Antibodies | 2 | 0.0 |
Blotting, Western | 5 | 0.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
In Vitro | 3 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Osmosis/physiology | 2 | 50.0 |
English Abstract | 5 | 0.0 |
Immunoblotting | 6 | 0.0 |
Kidney/metabolism | 3 | 0.0 |
Lung/metabolism | 2 | 1.0 |
*Membrane Proteins | 5 | 0.0 |
Microscopy, Immunoelectron | 6 | 1.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Rats | 15 | 0.0 |
Rats, Wistar | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 19 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 10 | 0.0 |
Skin/metabolism | 2 | 1.0 |
Water/chemistry | 2 | 5.0 |
Body Water/metabolism | 4 | 12.0 |
Molecular Conformation | 2 | 0.0 |
Signal Transduction | 2 | 0.0 |
Erythrocytes/*metabolism | 2 | 0.0 |
Escherichia coli/metabolism | 2 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Oocytes/metabolism | 6 | 3.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Saccharomyces cerevisiae/metabolism | 2 | 1.0 |
Time Factors | 2 | 0.0 |
Xenopus laevis | 9 | 2.0 |
Aquaporins/genetics/*metabolism | 6 | 27.0 |
Cells, Cultured | 4 | 0.0 |
Comparative Study | 4 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Osmolar Concentration | 4 | 0.0 |
RNA, Messenger/analysis | 4 | 0.0 |
Up-Regulation | 2 | 0.0 |
Female | 12 | 0.0 |
Gene Expression | 2 | 0.0 |
Pregnancy | 3 | 0.0 |
In Situ Hybridization | 3 | 0.0 |
Phylogeny | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Aquaporins/chemistry/*genetics/metabolism | 2 | 66.0 |
Biological Transport | 11 | 0.0 |
Kinetics | 4 | 0.0 |
Mutation | 5 | 0.0 |
Osmosis | 2 | 7.0 |
Phenotype | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Adult | 2 | 0.0 |
DNA, Complementary | 4 | 0.0 |
DNA, Complementary/analysis | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Glycerol/*metabolism | 3 | 27.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Water/*metabolism | 11 | 23.0 |
Gene Expression/drug effects | 2 | 0.0 |
Ion Channels/*biosynthesis | 2 | 40.0 |
Male | 9 | 0.0 |
Aquaporins/*physiology | 3 | 42.0 |
Kidney Tubules, Collecting/*physiology | 2 | 66.0 |
Mice, Knockout | 2 | 0.0 |
Aquaporins/*metabolism | 10 | 31.0 |
Aquaporins/chemistry/*genetics | 3 | 60.0 |
4-Chloromercuribenzenesulfonate/pharmacology | 2 | 22.0 |
Digestive Physiology | 2 | 8.0 |
Water-Electrolyte Balance/*physiology | 2 | 5.0 |
Models, Molecular | 3 | 0.0 |
Middle Aged | 2 | 0.0 |
Oocytes | 2 | 1.0 |
Cyclic AMP/metabolism | 2 | 0.0 |
Glycerol/metabolism | 4 | 10.0 |
Aged | 2 | 0.0 |
Mercuric Chloride/pharmacology | 3 | 23.0 |
Urea/metabolism | 2 | 4.0 |
Body Water/*metabolism | 3 | 13.0 |
*Escherichia coli Proteins | 2 | 0.0 |
*Membrane Glycoproteins | 2 | 0.0 |
Permeability | 4 | 2.0 |
*Ion Channels | 2 | 6.0 |
*Aquaporins | 15 | 19.0 |
Chromosome Mapping | 3 | 0.0 |
Ion Channels/*metabolism | 2 | 4.0 |
*Cell Membrane Permeability | 2 | 8.0 |
RNA, Messenger/biosynthesis | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
RNA, Complementary | 2 | 14.0 |
Kidney Tubules, Collecting/*metabolism | 2 | 33.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
*Membrane Transport Proteins | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Ion Channels/*genetics | 3 | 6.0 |
Infant, Newborn | 2 | 0.0 |
Kidney Concentrating Ability/physiology | 2 | 25.0 |
*Water-Electrolyte Balance | 2 | 4.0 |
Eye/metabolism | 2 | 14.0 |
